MedPath

Observational Prospective Study.at the End of the Study the Patients Will be Classified According to PH,Serum Bicarbonate and Serum Sodium Into 6 Groups and Statistical Analysis Will be Performed Using Spss

Completed
Conditions
Liver Cirrhosis
Interventions
Diagnostic Test: arterial blood gases and serum electrolytes
Registration Number
NCT05082064
Lead Sponsor
Sohag University
Brief Summary

1-to identify the prognostic value of serum bicarbonate and serum electrolytes at time of admission and their association with development of complications ,length of hospital stay ,prognosis and mortality in hospitalized cirrhotic patient

Detailed Description

the purpose of this study will be explore the impact of data obtained for the arterial blood gas parameters and serum bicarbonate and electrolytes at the time of hospital admission on adverse clinical outcomes ,duration of length of hospital stay and mortality in patients with cirrhosis .Furthermore incorporation these parameters into model of end stage liver disease could help to improve the prognostic value of MELDscore in comparison to the prognostic value of traditional equation of original MELD and child score

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
121
Inclusion Criteria

patients with confirmed diagnosis of cirrhosis (age >18 years ) who will be admitted to internal medicine department or will be admitted to intermediate care unit

  • willing and agree to be included in the study
Exclusion Criteria
  • patients without evidence of cirrhosis

  • cirrhotic patients whom -younger than 18 years old

    • have diabetic ketoacidosis
    • with acute coronary syndrome
    • with fulminant liver failure
    • with heart failure
    • with organ transplantation
    • when arterial blood gases not be available
    • patient refusal
    • patient with HCC

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
MELD group Barterial blood gases and serum electrolytesGroup B\>25
MELD-PACO2 Group Carterial blood gases and serum electrolytesGroup C\<25
MELD-BICARBONATE Group Farterial blood gases and serum electrolytesGroup F\>23
MELD -PACO2 Group Darterial blood gases and serum electrolytesGroup D\>25
MELD score group Aarterial blood gases and serum electrolytesMELD score :group A\<25
MELD-BICARBONATE score Group Earterial blood gases and serum electrolytesGroup E\<23
Primary Outcome Measures
NameTimeMethod
will be ICU admittedfrom the day of admission to the day of discharge from hospital or death during hospitalization

will be admitted to ICU due to progression of the disease

complications as shok,hepatorenal syndrome,severe infection,starting renal replacement therapy and icu intervention as mechanical ventilation using MELD score and child score depending on ABGparameters and serum electrolytes .

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Heba Allah fadel abd elrahman

🇪🇬

Sohag, Egypt

© Copyright 2025. All Rights Reserved by MedPath